Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christof Schaefer

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
European Journal of Clinical Pharmacology|January 27, 2021
Ivabradine use in pregnant women-treatment indications and pregnancy outcome: an evaluation of the German Embryotox databaseMaria Hoeltzenbein, Marie-Louise Lehmann, Evelin Beck, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|June 24, 2018
[Xenobiotics and pathogens in breast milk : A risk for the child?]Stephanie Padberg, Christoph Bührer, Juliane Menzel, et al.
BMC Pregnancy and Childbirth|August 26, 2022
Fetal adverse effects following NSAID or metamizole exposure in the 2nd and 3rd trimester: an evaluation of the German Embryotox cohortKatarina Dathe, Johanna Frank, Stephanie Padberg, et al.
Reproductive Toxicology (Elmsford, N.Y.)|June 19, 2018
Ethical approval for multicenter cohort studies on drug exposure during pregnancy: A survey among members of the European Network of Teratology Information Services (ENTIS)Ursula Winterfeld, Corinna Weber-Schöndorfer, Christof Schaefer, et al.
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|May 12, 2011
[Anaesthesia and breast-feeding: should breast-feeding be discouraged?]Peter Kranke, Torsten Frambach, Philip Schelling, et al.
Reproductive Toxicology (Elmsford, N.Y.)|May 30, 2017
Transient congenital dilated cardiomyopathy after maternal R-CHOP chemotherapy during pregnancyStephanie Padberg, Inge Mick, Cornelia Frenzel, et al.
Reproductive Toxicology (Elmsford, N.Y.)|May 20, 2021
First trimester naproxen exposure and outcome of pregnancy - A German case seriesStefanie Hultzsch, Wolfgang Paulus, Stephanie Padberg, et al.
Reproductive Toxicology (Elmsford, N.Y.)|July 19, 2018
Pregnancy outcome after first-trimester exposure to metformin: A prospective cohort studyStephan Scherneck, Natalie Schlinke, Evelin Beck, et al.
Pharmacoepidemiology and Drug Safety|February 4, 2015
Does the average drug exposure in pregnant women affect pregnancy outcome? A comparison of two approaches to estimate the baseline risks of adverse pregnancy outcomeEvelin Wacker, Ana Navarro, Reinhard Meister, et al.
Reproductive Toxicology (Elmsford, N.Y.)|May 22, 2012
Pregnancy outcome after paternal exposure to azathioprine/6-mercaptopurineMaria Hoeltzenbein, Corinna Weber-Schoendorfer, Cornelia Borisch, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
European Journal of Clinical Pharmacology|January 27, 2021
Ivabradine use in pregnant women-treatment indications and pregnancy outcome: an evaluation of the German Embryotox databaseMaria Hoeltzenbein, Marie-Louise Lehmann, Evelin Beck, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|June 24, 2018
[Xenobiotics and pathogens in breast milk : A risk for the child?]Stephanie Padberg, Christoph Bührer, Juliane Menzel, et al.
BMC Pregnancy and Childbirth|August 26, 2022
Fetal adverse effects following NSAID or metamizole exposure in the 2nd and 3rd trimester: an evaluation of the German Embryotox cohortKatarina Dathe, Johanna Frank, Stephanie Padberg, et al.
Reproductive Toxicology (Elmsford, N.Y.)|June 19, 2018
Ethical approval for multicenter cohort studies on drug exposure during pregnancy: A survey among members of the European Network of Teratology Information Services (ENTIS)Ursula Winterfeld, Corinna Weber-Schöndorfer, Christof Schaefer, et al.
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|May 12, 2011
[Anaesthesia and breast-feeding: should breast-feeding be discouraged?]Peter Kranke, Torsten Frambach, Philip Schelling, et al.
Reproductive Toxicology (Elmsford, N.Y.)|May 30, 2017
Transient congenital dilated cardiomyopathy after maternal R-CHOP chemotherapy during pregnancyStephanie Padberg, Inge Mick, Cornelia Frenzel, et al.
Reproductive Toxicology (Elmsford, N.Y.)|May 20, 2021
First trimester naproxen exposure and outcome of pregnancy - A German case seriesStefanie Hultzsch, Wolfgang Paulus, Stephanie Padberg, et al.
Reproductive Toxicology (Elmsford, N.Y.)|July 19, 2018
Pregnancy outcome after first-trimester exposure to metformin: A prospective cohort studyStephan Scherneck, Natalie Schlinke, Evelin Beck, et al.
Pharmacoepidemiology and Drug Safety|February 4, 2015
Does the average drug exposure in pregnant women affect pregnancy outcome? A comparison of two approaches to estimate the baseline risks of adverse pregnancy outcomeEvelin Wacker, Ana Navarro, Reinhard Meister, et al.
Reproductive Toxicology (Elmsford, N.Y.)|May 22, 2012
Pregnancy outcome after paternal exposure to azathioprine/6-mercaptopurineMaria Hoeltzenbein, Corinna Weber-Schoendorfer, Cornelia Borisch, et al.
Pageof 10